| Roche Pharma (Schweiz) AG - Pulmozyme, Inhalationslösung |
| 52623 | | 01 | | Pulmozyme | | Inhalationslösung | | R05CB13 | | Dornase Alfa (Desoxyribonuclease) | | 28.04.1994 | | |
|
| Composition |
| dornasum alfa 2.5 mg, natrii chloridum, calcii chloridum dihydricum, aqua ad iniectabile ad solutionem pro 2.5 ml. |
| Packungsbestandteile |
| Inhalation solution | | | | | | | | Active Agent | Dose |
|---|
| Dornase Alfa | 2.5mg / 2.5ml |
| | BAG: Active Agent | Dose |
|---|
| Dornase Alfa | 2.5 mg |
| | | | Inactive agents |
|---|
| Calcii Chloridum Dihydricum | | Sodium Chloride |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 014 | 5 x 6 ampoule(s) | 684.62 | 761.00 | B | SL | No |
|
